A MONUMENTAL FINDING
Discovered by research scientist Dr. P. R. Raghavan, the patented formula in NANO SOMA (Metadichol) represents an innovative modern breakthrough that addresses immune dysfunction at the cellular level. Formulated using nanotechnology as both a dietary supplement and as a topical solution, this incredible discovery (which comes from a powerful plant wax extracted from sugarcane) has been found to support many of the physiological functions essential for optimal skin and immune health.
After spending decades in the pharmaceutical industry, Dr. Raghavan witnessed the troubling increase in the number of drugs reaching the market while things like diabetes, high blood pressure and high cholesterol continued rising despite this. Applying his extensive research in drug metabolism and biochemistry, including 25 years in drug discovery with Columbia University, Max Planck Institute, Ciba-Geigy, and Boehringer Ingelheim, Dr. Raghavan sought a smarter, safer, non-drug alternative. In 2008, his research led to the discovery of the patented formula in NANO SOMA known as Metadichol, a plant-based emulsion of nano policosanol that the body can recognize and utilize efficiently.
Metadichol® Products Are Protected by The Following Approved Patents:
US Patent No. US 8,722,093 B2
METADICHOL US -APPROVED PATENT
A method of increasing serum vitamin C level in a subject
A method of inhibiting NF-κB protein level in a subject
A method of increasing adiponectin level in a subject
A method of reducing TNF alpha level in a subject
US Patent No. US 9,006,292 B2
Metadichol ® Gel and liquid Nanoparticle Formulations
A method of treating a skin disease in a subject, comprising: psoriasis, atopic dermatitis, contact dermatitis and other eczematous dermatitis’s, seborrhoeic dermatitis, neurodermatitis, decubitus, lichen planus, pemphigus, bullate pemphigoid, epidermolysis bullosa, urticaria, angioedemas, vasculitides, erythema, cutaneous, eosinophilias, lupus erythematosuseczema, and MRSA, basal cell carcinoma
A method of treating a disease by improving a physiologic or metabolic parameter in a subject. The said method comprising: Increasing serum APO A1 protein, hemoglobin, platelet count; Reducing lipoprotein-a, uric acid, elevated AST:ALT ratio, ferritin, bilirubin, PTH, calcium, creatinine, alkaline phosphatase, BUN, phosphorus levels; Regulating eGFR level, neutrophils, monocytes, white blood cell, thyroid hormone (TSH).
The method of claim wherein said disease is: kidney disease, MRSA infection, MDS, hematological disease, prostate cancer, and eczema.
US Patent No. US 9,034,383 B2
Policosanol supplementation has the potential to lower blood levels of insulin resistance and the proinflammatory cytokines and increase in vitamin C levels.
Octacosanol supplementation has the potential to lower blood levels of insulin resistance, and decrease levels of pro inflammatory cytokines increase levels of VEGF (vascular endothelial growth factor).